BEc (Hons) (UTAS), MEc (UTAS), PhD (Sydney)

Rosalie Viney is Professor of Health Economics and Director of the Centre for Health Economics Research and Evaluation at the University of Technology Sydney. She has extensive experience in health economics, health services and health policy research. Her research interests include health technology assessment and priority setting, measurement and valuation of quality of life and health outcomes, consumer preferences for health and health care, evaluation of health policy, and the impact of funding arrangements on utilisation and outcomes of health care. Rosalie has undertaken a broad range of commissioned projects for State/Territory Health authorities, and for the Australian Government Department of Health. Rosalie has also had longstanding involvement in the fields of health economics and health services research in Australia, through the Australian Health Economics Society and the Health Services Research Association of Australia and New Zealand, and is currently a member of the Board of the International Health Economics Association and of the Scientific Executive of the EuroQol Foundation.

Associate Editor, Health Economics 2016 -2020

Member, NHMRC Research Committee (2015-2018 and 2018-2021 trienniums)

Member, Pharmaceutical Benefits Advisory Committee 2005-2017

Member, Economics Sub-Committee of PBAC 2001-2017

Chair, ESC of PBAC 2009-2017

Member, Life Saving Drugs Expert Panel, 2020-current

Treasurer and Board Member, International Health Economics Association, 2020- current

Member, Scientific Executive, EuroQol Research Foundation, 2017-current (currently Deputy Chair)

Member, Euroqol Group

Fiebig, D., Viney, R.C., Haas, M., Hole, A.R., Bateson, D., Street, D., Weisberg, E. & Knox, S. 2016, 'Consideration sets and their role in modelling doctor recommendations about contraceptives', Health Economics.

Viney, R.C., Norman, R., Brazier, J.E., Cronin, P.A., King, M.T., Ratcliffe, J. & Street, D. 2014, 'An Australian discrete choice experiment to value EQ-5D health states', Health Economics, vol. 23, no. 6, pp. 729-742.

Parkinson, B., Viney, R.C., Haas, M., Goodall, S., Srasuebkul, P. & Pearson, S.A. 2016, 'Real world evidence: a comparison of the Australian Herceptin Program and clinical trials of trastuzumab for HER2+ metastatic breast cancer', PharmacoEconomics, vol. 34, no. 10, pp. 1039-1050.

Norman, R., Viney, R.C., Aaronson, N.K., Brazier, J.E., Cella, D., Costa, D.S., Fayers, P.M., Kemmler, G., Peacock, S., Pickard, A.S., Rowen, D., Street, D.J., Velikova, G., Young, T.A. & King, M.T. 2016, 'Using a discrete choice experiment to value the QLU-C10D: feasibility and sensitivity to presentation format', Quality of Life Research, vol. 25, no. 3, pp. 637-649

Reeve, R., Arora, S., Butler, K., Viney, R., Burns, L., Goodall, S. & van Gool, K. 2016, 'Evaluating the impact of hospital based drug and alcohol consultation liaison services', Journal of Substance Abuse Treatment, vol. 68, pp. 36-45.